Tag: biosurgery industry

  • 2024 Biosurgery Market Summary: 5 Key Findings

    2024 Biosurgery Market Summary: 5 Key Findings

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Projections are in Place for the Biosurgery Market Between 2024-2033?

    In recent times, there has been a substantial growth in the size of the biosurgery market. The growth is projected to increase from $14.01 billion in 2023 to $15.18 billion in 2024 with a compound annual growth rate (CAGR) of 8.4%. Factors such as the increase in surgical procedures, rise in chronic diseases, an expanding elderly population, a shift towards biodegradable products, and changes in regulations and approvals have all contributed to this historical period growth.

    The biosurgery market is projected to experience significant expansion in the forthcoming years, reaching $20.87 billion in 2028 with a Compound Annual Growth Rate (CAGR) of 8.3%. The predicted increase during the forecast period can be linked to improvements in tissue engineering, an increase in minimally invasive procedures, a focus on regenerative medicine, a shift towards biologics, and the needs of the aging population. The forecast period is set to witness key trends such as an expansion in minimally invasive procedures, an increase in cosmetic and plastic surgeries, emphasis on stem cell therapies, advancements in wound care, and the creation of biodegradable products.

    Claim Your Free Sample of the Global Biosurgery Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp

    What Are the Major Factors Contributing to the biosurgery Market Expansion?

    The escalating occurrence of chronic ailments is predicted to accelerate the expansion of the biosurgery market in the forthcoming period. Chronic diseases are long-lasting health issues which necessitate proposed and continuous medical intervention and prevent regular activities or both. Predominant causes for death and disability in the United States are chronic diseases like diabetes, cancer, and cardiac ailments. Biosurgery is applied to eradicate necrotic tissue, diminish the risk of sepsis and expedite the healing mechanism for chronic wounds. For instance, in March 2022, data provided by the Australian Bureau of Statistics, an autonomous statutory agency in Australia charged with the collection and analysis of data, and making data-driven recommendations to federal, state and territorial governments, indicated that seventy-eight percent (78.6%) of Australians had at least one chronic disease. Over half of the population, equating to 11.6 million people, suffered from at least one chronic disease. Consequently, the escalating incidence of chronic disease is fueling the expansion of the biosurgery market.

    Which Key Segments Shape the Biosurgery Market?

    1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement

    2) By Source: Natural or Biologics Products, Synthetic Products

    3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications

    4) By End-User: Hospitals, Clinics, Other End-Users

    What Are the Transformative Trends Influencing the Biosurgery Market?

    Product innovations are rising to prominence as a crucial trend in the biosurgery market. This is primarily due to the leading companies operating in the market focusing on such innovations to enhance their market standing. For instance, in April 2021, Aroa Biosurgery, a New Zealand-based firm that specializes in medical and surgical products, introduced Myriad Morcells. This Myriad Matrix morcellized (powder) configuration can be easily adjusted to improve interactions with irregular wound beds. It delivers a surge of biologically essential ECM proteins in a way that fits the wound’s specifics, facilitating the start of the healing process. The Myriad Matrix is a multi-layered extracellular matrix (ECM) graft with a significant volume and surface area, and it contains interstitial spaces that cells can quickly access. This product uses Aroa ECM bioscaffold technology, which includes important secondary chemicals and persisting vascular channels to aid the development of new tissue.

    Order Now for Fast Delivery of Your Biosurgery Market Report!

    https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

    What Regions Are Leading the Growth Trajectory of the Biosurgery Market?

    North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Biosurgery Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biosurgery market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Biosurgery Market Include

    1. Biosurgery Market Executive Summary

    2. Biosurgery Market Segments

    3. Biosurgery Market Size And Template Market Growth Rate

    4. Key Biosurgery Market Trends

    5. Major Biosurgery Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Biosurgery Market

    26. Top Biosurgery Companies

    27. Biosurgery Market Opportunities And Strategies

    28. Biosurgery Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Understand How The Biosurgery Market Is Poised To Grow Through 2024-2033

    Understand How The Biosurgery Market Is Poised To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Biosurgery Global Market Report 2024, the biosurgery market is expected to show significant growth in the forecast period.

    In recent years, the biosurgery market has witnessed robust growth, driven by factors such as increasing surgical procedures, rising chronic diseases, and a growing geriatric population. This blog explores the dynamics of the biosurgery market, its growth prospects, and the key trends shaping its trajectory.

    Market Overview

    • The biosurgery market size surged from $14.01 billion in 2023 to $15.18 billion in 2024, boasting a compound annual growth rate (CAGR) of 8.4%.
    • Looking ahead, the market is projected to reach $20.87 billion by 2028, with a CAGR of 8.3%.

    Factors Driving Growth

    1. Rising Prevalence of Chronic Diseases
      • Chronic diseases such as diabetes, cancer, and heart disease are on the rise globally, necessitating ongoing medical care and driving demand for biosurgery solutions.
      • In Australia, for instance, over 78.6% of the population suffers from at least one chronic illness, fueling the need for effective biosurgery interventions.
    2. Product Innovation Revolutionizing Wound Healing
      • Major companies are focusing on product innovations to enhance wound healing and drive market growth.
      • Innovations like Aroa Biosurgery’s Myriad Morcells leverage extracellular matrix (ECM) technology to kickstart healing processes and improve interaction with uneven wound beds.
    3. Strategic Acquisitions and Expansions
      • Strategic acquisitions, such as Becton, Dickinson and Company’s acquisition of Tissuemed Ltd., bolster companies’ technological portfolios and global presence.
      • These acquisitions strengthen market leaders’ positions and expand their offerings in the biosurgery segment.

    Market Segmentation

    1. By Product
      • Includes Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, and Staple Line Reinforcement.
    2. By Source
      • Natural or Biologics Products and Synthetic Products.
    3. By Application
      • Encompasses Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, and Other Applications.
    4. By End-User
      • Hospitals, Clinics, and Other End-Users.

    Regional Insights

    • North America emerged as the largest region in the biosurgery market in 2023, highlighting its significant market presence.
    • Asia-Pacific is poised to be the fastest-growing region during the forecast period, reflecting increasing healthcare investments and the rising adoption of advanced surgical techniques.

    Future Trends and Opportunities

    • Growth in Minimally Invasive Procedures: The market will witness a surge in minimally invasive surgeries, driving demand for innovative biosurgery products.
    • Rise in Cosmetic and Plastic Surgeries: Increasing aesthetic consciousness will lead to a rise in cosmetic and plastic surgeries, expanding the biosurgery market.
    • Focus on Stem Cell Therapies: Advancements in regenerative medicine and stem cell therapies will open new avenues for biosurgery applications.
    • Advancements in Wound Care: Continued advancements in wound care technologies will enhance healing outcomes and patient satisfaction.
    • Development of Biodegradable Products: The shift towards biodegradable products aligns with environmental sustainability goals and addresses concerns regarding product safety and efficacy.

    Conclusion
    The biosurgery market is poised for substantial growth, driven by the rising prevalence of chronic diseases, product innovations, and strategic acquisitions. With a focus on advancing surgical techniques, regenerative medicine, and biodegradable solutions, the biosurgery market is set to address evolving healthcare needs and improve patient outcomes globally.

    View More On The Biosurgery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

    Request A Sample Of The Global Biosurgery Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9380&type=smp